Gastroenterology and Hepatology from Bed to Bench

Riordan SM, Williams R. Treatment of hepatic encephalopathy. New England Journal of Medicine. 1997;337(7):473-9.

Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716-21.

Mousseau D, Baker G, Butterworth R. Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy. Journal of neurochemistry. 1997;68(3):1200-8.

Yurdaydin C, Karavelioǧlu D, Onaran O, Çelik T, Yaşa MH, Uzunalimoǧlu Ö. Opioid receptor ligands in human hepatic encephalopathy. Journal of hepatology. 1998;29(5):796-801.

Jalan R, Turjanski N, Taylor-Robinson SD, Koepp M, Richardson M, Wilson J, et al. Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis. Gut. 2000;46(4):546-52.

Odeh M, Sabo E, Srugo I, Oliven A. Serum levels of tumor necrosis factor‐α correlate with severity of hepatic encephalopathy due to chronic liver failure. Liver International. 2004;24(2):110-6.

Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. Journal of hepatology. 2004;40(2):247-54.

Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60(2):715-35.

Saab S. Evaluation of the impact of rehospitalization in the management of hepatic encephalopathy. International journal of general medicine. 2015;8:165.

Bajaj J, Sanyal A, Bell D, Gilles H, Heuman D. Predictors of the recurrence of hepatic encephalopathy in lactulose‐treated patients. Alimentary pharmacology & therapeutics. 2010;31(9):1012-7.

Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, et al. Rifaximin treatment in hepatic encephalopathy. New England Journal of Medicine. 2010;362(12):1071-81.

Mullen KD, Sanyal AJ, Bass NM, Poordad FF, Sheikh MY, Frederick RT, et al. Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy. Clinical Gastroenterology and Hepatology. 2014;12(8):1390-7. e2.

Sharma P, Sharma BC. Management of overt hepatic encephalopathy. Journal of clinical and experimental hepatology. 2015;5:S82-S7.

Dhiman RK. Gut microbiota and hepatic encephalopathy. Metabolic brain disease. 2013;28(2):321-6.

Bajaj JS, Ridlon JM, Hylemon PB, Thacker LR, Heuman DM, Smith S, et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2012;302(1):G168-G75.

Shawcross D, Sharifi Y, Canavan J, Yeoman A, Abeles R, Taylor N, et al. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. Journal of hepatology. 2011;54(4):640-9.

Solga SF. Probiotics can treat hepatic encephalopathy. Medical hypotheses. 2003;61(2):307-13.

Sanders ME, Marco ML. Food formats for effective delivery of probiotics. Annual Review of Food Science and Technology. 2010;1:65-85.

Shimakawa Y, Matsubara S, Yuki N, Ikeda M, Ishikawa F. Evaluation of Bifidobacterium breve strain Yakult-fermented soymilk as a probiotic food. International journal of food microbiology. 2003;81(2):131-6.

Tsangalis D, Shah NP. Metabolism of oligosaccharides and aldehydes and production of organic acids in soymilk by probiotic bifidobacteria. International journal of food science & technology. 2004;39(5):541-54.

Cheng I-C, Shang H-F, Lin T-F, Wang T-H, Lin H-S, Lin S-H. Effect of fermented soy milk on the intestinal bacterial ecosystem. World journal of gastroenterology: WJG. 2005;11(8):1225.

Chow J. Probiotics and prebiotics: a brief overview. Journal of Renal Nutrition. 2002;12(2):76-86.

Greenberger NJ, Carley J, Schenker S, Bettinger I, Stamnes C, Beyer P. Effect of vegetable and animal protein diets in chronic hepatic encephalopathy. Digestive Diseases and Sciences. 1977;22(10):845-55.

Bianchi G, Marchesini G, Fabbri A, Rondelli A, Bugianesi E, Zoli M, et al. Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross‐over comparison. Journal of internal medicine. 1993;233(5):385-92.

Thananunkul D, TANAKA M, Chichester C, LEE TC. DEGRADATION OF RAFFINOSE AND STACHYOSE IN SOYBEAN MILK BY α‐GALACTOSIDASE FROM Mortierella vinacea. Entrapment of α‐galactosidase within polyacrylamide gel. Journal of Food Science. 1976;41(1):173-5.

Favaro Trindade C, Terzi S, Trugo L, Della Modesta R, Couri S. Development and sensory evaluation of soy milk based yoghurt. Archivos latinoamericanos de nutrición. 2001;51(1):100-4.

Berghofer E, Grzeskowiak B, Mundigler N, Sentall W, Walcak J. Antioxidative properties of faba bean-, soybean-and oat tempeh. International journal of food sciences and nutrition. 1998;49(1):45-54.

Esaki H, Onozaki H, Osawa T. Antioxidative activity of fermented soybean products. ACS Publications; 1994.

Chien H-L, Huang H-Y, Chou C-C. Transformation of isoflavone phytoestrogens during the fermentation of soymilk with lactic acid bacteria and bifidobacteria. Food microbiology. 2006;23(8):772-8.

Donkor ON, Nilmini S, Stolic P, Vasiljevic T, Shah N. Survival and activity of selected probiotic organisms in set-type yoghurt during cold storage. International Dairy Journal. 2007;17(6):657-65.

Buriti FC, Castro IA, Saad SM. Viability of Lactobacillus acidophilus in synbiotic guava mousses and its survival under in vitro simulated gastrointestinal conditions. International Journal of Food Microbiology. 2010;137(2):121-9.

Hernandez-Hernandez O, Muthaiyan A, Moreno F, Montilla A, Sanz M, Ricke S. Effect of prebiotic carbohydrates on the growth and tolerance of Lactobacillus. Food microbiology. 2012;30(2):355-61.

Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clinical Gastroenterology and Hepatology. 2005;3(7):705-13.

Kuwahata M, Kubota H, Kanouchi H, Ito S, Ogawa A, Kobayashi Y, et al. Supplementation with branched-chain amino acids attenuates hepatic apoptosis in rats with chronic liver disease. Nutrition research. 2012;32(7):522-9.

Marchesini G, Dioguardi F, Bianchi G, Zoli M, Bellati G, Roffi L, et al. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy: a randomized double-blind casein-controlled trial. Journal of hepatology. 1990;11(1):92-101.

Les I, Doval E, García-Martínez R, Planas M, Cárdenas G, Gómez P, et al. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. The American journal of gastroenterology. 2011;106(6):1081.

Córdoba J, López-Hellı́n J, Planas M, Sabı́n P, Sanpedro F, Castro F, et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. Journal of hepatology. 2004;41(1):38-43.

Huth P, Miller G, Brown P. Milk-A key to new products. Dairy Foods. 2003;104(9):46-.

Gaudel C, Nongonierma AB, Maher S, Flynn S, Krause M, Murray BA, et al. A whey protein hydrolysate promotes insulinotropic activity in a clonal pancreatic β-cell line and enhances glycemic function in ob/ob mice. The Journal of nutrition. 2013;143(7):1109-14.

Hassan AM, Abdel-Aziem SH, Abdel-Wahhab MA. Modulation of DNA damage and alteration of gene expression during aflatoxicosis via dietary supplementation of Spirulina (Arthrospira) and whey protein concentrate. Ecotoxicology and environmental safety. 2012;79:294-300.

Petyaev IM, Dovgalevsky PY, Klochkov VA, Chalyk NE, Kyle N. Whey protein lycosome formulation improves vascular functions and plasma lipids with reduction of markers of inflammation and oxidative stress in prehypertension. The Scientific World Journal. 2012;2012.

Rabbani P, Prasad AS. Plasma ammonia and liver ornithine transcarbamoylase activity in zinc-deficient rats. American Journal of Physiology-Endocrinology and Metabolism. 1978;235(2):E203.

Prasad AS, Rabbani P, Abbasii A, Bowersox E, Fox MS. Experimental zinc deficiency in humans. Annals of Internal Medicine. 1978;89(4):483-90.

Van Der Rijt CC, Schalm SW, Schat H, Foeken K, De Jong G. Overt hepatic encephalopathy precipitated by zinc deficiency. Gastroenterology. 1991;100(4):1114-8.

Häussinger D, Schliess F. Pathogenetic mechanisms of hepatic encephalopathy. Gut. 2008;57(8):1156-65.

Brusilow S, Traystman R. Hepatic encephalopathy. The New England journal of medicine. 1986;314(12):786-7; author reply 7.

Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid‐nitrogen metabolism in patients with advanced cirrhosis. Hepatology. 1996;23(5):1084-92.

Tuerk MJ, Fazel N. Zinc deficiency. Current opinion in gastroenterology. 2009;25(2):136-43.

Schliess F, Görg B, Häussinger D. RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia. Metabolic brain disease. 2009;24(1):119.

Cunniff P. Official methods of analysis of AOAC International: Association of Official Analytical Chemists.; 1996.

Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Analytical biochemistry. 1996;239(1):70-6.

Feng P, Weagant SD, Grant MA, Burkhardt W, Shellfish M, Water B. BAM: Enumeration of Escherichia coli and the Coliform Bacteria. Bacteriological analytical manual. 2002:13-9.

Bennett R, Lancette G. Staphylococcus aureus Food and Drug Administration; 2001 [Updated 03/2016]. 2001.

Iran IoSaIRo. Milk and milk products-enumeration of presumptive Esherichia coli-most probable number (MPN). 2015.

Moezi L, Heidari R, Amirghofran Z, Nekooeian AA, Monabati A, Dehpour AR. Enhanced anti-ulcer effect of pioglitazone on gastric ulcers in cirrhotic rats: the role of nitric oxide and IL-1β. Pharmacological Reports. 2013;65(1):134-43.

Ara C, Kirimlioglu H, Karabulut AB, Coban S, Ay S, Harputluoglu M, et al. Protective effect of resveratrol against oxidative stress in cholestasis. Journal of Surgical Research. 2005;127(2):112-7.

Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. British journal of experimental pathology. 1984;65(3):305.

Eftekhari MH, Ershad M, Oryan A. Hepatoprotective effects of soy protein isolate against dimethylnitrosamine-induced acute liver injury in Sprague Dawley rat. Mediterranean Journal of Nutrition and Metabolism. 2013;6(1):23-9.

Mohd Yusof H, Ali NM, Yeap SK, Ho WY, Beh BK, Koh SP, et al. Hepatoprotective effect of fermented soybean (nutrient enriched soybean tempeh) against alcohol-induced liver damage in mice. Evidence-Based Complementary and Alternative Medicine. 2013;2013.

Ustundag B, Bahcecioglu IH, Sahin K, Duzgun S, Koca S, Gulcu F, et al. Protective effect of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental nonalcoholic steatohepatitis model. Digestive diseases and sciences. 2007;52(8):2006-14.

Liu H, Zhong H, Leng L, Jiang Z. Effects of soy isoflavone on hepatic steatosis in high fat-induced rats. Journal of clinical biochemistry and nutrition. 2017;61(2):85-90.

Li J-F, Chen B-C, Lai D-D, Jia Z-R, Andersson R, Zhang B, et al. Soy isoflavone delays the progression of thioacetamide-induced liver fibrosis in rats. Scandinavian journal of gastroenterology. 2011;46(3):341-9.

Riggio O, Merli M, Capocaccia L, Caschera M, Zullo A, Pinto G, et al. Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis. Hepatology. 1992;16(3):785-9.

Mansour DF, Salama A, Hegazy RR, Omara EA, Nada SA. Whey protein isolate protects against cyclophosphamide-induced acute liver and kidney damage in rats. J appl pharm sci. 2017;7(06):111-20.

Rishi P, Mavi SK, Bharrhan S, Shukla G, Tewari R. Protective efficacy of probiotic alone or in conjunction with a prebiotic in Salmonella-induced liver damage. FEMS microbiology ecology. 2009;69(2):222-30.

Khalesi S, Johnson DW, Campbell K, Williams S, Fenning A, Saluja S, et al. Effect of probiotics and synbiotics consumption on serum concentrations of liver function test enzymes: a systematic review and meta-analysis. European journal of nutrition. 2017:1-17.

Zhang X-l, Wu Y-f, Wang Y-s, Wang X-z, Piao C-h, Liu J-m, et al. The protective effects of probiotic-fermented soymilk on high-fat diet-induced hyperlipidemia and liver injury. Journal of Functional Foods. 2017;30:220-7.

D'argenio G, Cariello R, Tuccillo C, Mazzone G, Federico A, Funaro A, et al. Symbiotic formulation in experimentally induced liver fibrosis in rats: intestinal microbiota as a key point to treat liver damage? Liver International. 2013;33(5):687-97.

Adawi D, Ahrné S, Molin G. Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model. International journal of food microbiology. 2001;70(3):213-20.

Devière J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, et al. Excessive in vitro bacterial lipopolysaccharide‐induced production of monokines in cirrhosis. Hepatology. 1990;11(4):628-34.

Such J, Hillebrand DJ, Guarner C, Berk L, Zapater P, Westengard J, et al. Tumor necrosis factor-α, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection. Digestive diseases and sciences. 2001;46(11):2360-6.

Wright G, Jalan R. Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box? Hepatology. 2007;46(2):291-4.

Lin C-Y, Tsai Z-Y, Cheng I-C, Lin S-H. Effects of fermented soy milk on the liver lipids under oxidative stress. World journal of gastroenterology. 2005;11(46):7355.

Weber FL, Jr., Minco D, Fresard KM, Banwell JG. Effects of vegetable diets on nitrogen metabolism in cirrhotic subjects. Gastroenterology. 1985;89(3):538-44.

Rudloff S, Kunz C. Protein and nonprotein nitrogen components in human milk, bovine milk, and infant formula: quantitative and qualitative aspects in infant nutrition. Journal of pediatric gastroenterology and nutrition. 1997;24(3):328-44.

Tomiya T, Inoue Y, Yanase M, Arai M, Ikeda H, Tejima K, et al. Leucine stimulates the secretion of hepatocyte growth factor by hepatic stellate cells. Biochemical and biophysical research communications. 2002;297(5):1108-11.

Cummings JH, Branch W, Jenkins DJ, Southgate DA, Houston H, James WP. Colonic response to dietary fibre from carrot, cabbage, apple, bran. Lancet (London, England). 1978;1(8054):5-9.

Stephen AM, Cummings JH. Mechanism of action of dietary fibre in the human colon. Nature. 1980;284(5753):283-4.

Gaudel C, Nongonierma AB, Maher S, Flynn S, Krause M, Murray BA, et al. A whey protein hydrolysate promotes insulinotropic activity in a clonal pancreatic beta-cell line and enhances glycemic function in ob/ob mice. The Journal of nutrition. 2013;143(7):1109-14.

Hassan AM, Abdel-Aziem SH, Abdel-Wahhab MA. Modulation of DNA damage and alteration of gene expression during aflatoxicosis via dietary supplementation of Spirulina (Arthrospira) and Whey protein concentrate. Ecotoxicology and environmental safety. 2012;79:294-300.

Petyaev IM, Dovgalevsky PY, Klochkov VA, Chalyk NE, Kyle N. Whey protein lycosome formulation improves vascular functions and plasma lipids with reduction of markers of inflammation and oxidative stress in prehypertension. TheScientificWorldJournal. 2012;2012:269476.

Mansour D, Nada S, El-Denshary E, Omara E, Asaad G, Abdel-Rahman R. Milk whey proteins modulate endotoxemia-induced hepatotoxicity in rats. Int J Pharm Pharm Sci. 2015;7:65-71.

Nada SA, Hassan NF, Eldenshary EE-DS, Reheem GA, Hassan AH. Whey protein products and their combination with L-methionine prevent liver fibrosis incidence in thioacetamide-toxicated rats. IOSR Journal Of Pharmacy. 2015;5:19-28.

Bounous G. Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. Anticancer research. 2000;20(6):4785-92.

Bounous G, Molson JH. The antioxidant system. Anticancer research. 2003;23(2b):1411-5.

Ganai AA, Husain M. Genistein attenuates D-GalN induced liver fibrosis/chronic liver damage in rats by blocking the TGF-β/Smad signaling pathways. Chemico-biological interactions. 2017;261:80-5.

Ganai AA, Khan AA, Malik ZA, Farooqi H. Genistein modulates the expression of NF-κB and MAPK (p-38 and ERK1/2), thereby attenuating d-Galactosamine induced fulminant hepatic failure in Wistar rats. Toxicology and applied pharmacology. 2015;283(2):139-46.

Mard SA, Akbari G, Dianat M, Mansouri E. Protective effects of crocin and zinc sulfate on hepatic ischemia-reperfusion injury in rats: a comparative experimental model study. Biomedicine & Pharmacotherapy. 2017;96:48-55.

Shi F, Sheng Q, Xu X, Huang W, Kang YJ. Zinc supplementation suppresses the progression of bile duct ligation-induced liver fibrosis in mice. Experimental Biology and Medicine. 2015;240(9):1197-204.

Hayashi M, Ikezawa K, Ono A, Okabayashi S, Hayashi Y, Shimizu S, et al. Evaluation of the effects of combination therapy with branched‐chain amino acid and zinc supplements on nitrogen metabolism in liver cirrhosis. Hepatology Research. 2007;37(8):615-9.